California Institute for Regenerative Medicine

company

About

The California Institute for Regenerative Medicine (The Institute or CIRM) was established in early 2005 following the passage of

  • 51 - 100

Details

Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2005
Number Of Employee
51 - 100
Operating Status
Active
Investor Type
MVC

The California Institute for Regenerative Medicine ("The Institute" or "CIRM") was established in early 2005 following the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters on November 2, 2004, and called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities.

The mission of CIRM is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury.

Investments

Number of Investments
Number of Lead Investments
2
2
California Institute for Regenerative Medicine has made 2 investments. Their most recent investment was on Jan 22, 2018, when Medeor Therapeutics raised $18.80M.
Date Company Name
Round Money Raised Industry Lead Investor
Grant $18.80M Biotechnology Yes
Oct 27, 2012 Bluebird Bio
Series Unknown $9.30M Biotechnology Yes